Zhu B - Search Results

1

Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.

Xing Q, Ji C, Zhu B, Cong R, Wang Y. Xing Q, et al. Among authors: zhu b. Cancer Med. 2020 Oct;9(19):7034-7051. doi: 10.1002/cam4.3367. Epub 2020 Aug 11. Cancer Med. 2020. PMID: 32780567 Free PMC article.

2

MiR-455-5p Suppresses the Progression of Prostate Cancer by Targeting CCR5.

Xing Q, Xie H, Zhu B, Sun Z, Huang Y. Xing Q, et al. Among authors: zhu b. Biomed Res Int. 2019 Apr 11;2019:6394784. doi: 10.1155/2019/6394784. eCollection 2019. Biomed Res Int. 2019. PMID: 31111062 Free PMC article.

3

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma.

Wang Y, Cong R, Liu S, Zhu B, Wang X, Xing Q. Wang Y, et al. Among authors: zhu b. Cancer Cell Int. 2021 Jan 11;21(1):46. doi: 10.1186/s12935-020-01738-2. Cancer Cell Int. 2021. PMID: 33430867 Free PMC article.

4

A Novel Nine Apoptosis-Related Genes Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma and its Associations with Immune Infiltration.

Wang Y, Chen Y, Zhu B, Ma L, Xing Q. Wang Y, et al. Among authors: zhu b. Front Mol Biosci. 2021 Mar 4;8:567730. doi: 10.3389/fmolb.2021.567730. eCollection 2021. Front Mol Biosci. 2021. PMID: 33748185 Free PMC article.

5

Survival Prognosis, Tumor Immune Landscape, and Immune Responses of PPP1R18 in Kidney Renal Clear Cell Carcinoma and Its Potentially Double Mechanisms.

Wang Y, Liu S, Chen Y, Zhu B, Xing Q. Wang Y, et al. Among authors: zhu b. World J Oncol. 2022 Feb;13(1):27-37. doi: 10.14740/wjon1446. Epub 2022 Feb 28. World J Oncol. 2022. PMID: 35317332 Free PMC article.

6

Survival Prognosis, Tumor Immune Landscape, and Immune Responses of ADAMTS14 in Clear Cell Renal Cell Carcinoma and Its Potential Mechanisms.

Chen Y, Ji H, Liu S, Xing Q, Zhu B, Wang Y. Chen Y, et al. Among authors: zhu b. Front Immunol. 2022 Apr 29;13:790608. doi: 10.3389/fimmu.2022.790608. eCollection 2022. Front Immunol. 2022. PMID: 35572505 Free PMC article.

7

High expression of PI4K2A predicted poor prognosis of colon adenocarcinoma (COAD) and correlated with immunity.

Huang X, Cao Y, Bao P, Zhu B, Cheng Z. Huang X, et al. Among authors: zhu b. Cancer Med. 2023 Jan;12(1):837-851. doi: 10.1002/cam4.4895. Epub 2022 May 30. Cancer Med. 2023. PMID: 35634680 Free PMC article.

8

COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks.

Liu S, Yu Y, Wang Y, Zhu B, Han B. Liu S, et al. Among authors: zhu b. Eur J Med Res. 2022 Jul 16;27(1):122. doi: 10.1186/s40001-022-00745-5. Eur J Med Res. 2022. PMID: 35842702 Free PMC article.

9

Identification of hub biomarkers and exploring the roles of immunity, M6A, ferroptosis, or cuproptosis in rats with diabetic erectile dysfunction.

Wang Y, Zhang X, Chen Y, Zhu B, Xing Q. Wang Y, et al. Among authors: zhu b. Andrology. 2023 Feb;11(2):316-331. doi: 10.1111/andr.13265. Epub 2022 Aug 24. Andrology. 2023. PMID: 35975587 Free article.

10

Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinoma.

Wang Y, Ji H, Zhu B, Xing Q, Xie H. Wang Y, et al. Among authors: zhu b. Eur J Immunol. 2023 Jan;53(1):e2250105. doi: 10.1002/eji.202250105. Epub 2022 Nov 24. Eur J Immunol. 2023. PMID: 36367018 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,418 results

Search Page

Filters